1. | Kennel SJ, Foote LJ, Flynn KM. Tumor antigen on benign adenomas and on murine lung carcinomas quantitated by a two-site monoclonal antibody assay. Cancer Res. 1986;46:707-12. (Immunogen, IP) | 2. | Kennel SJ, Foote LJ, Falcioni R, Sonnenberg A, Stringer CD, Crouse C, et al. Analysis of the tumor-associated antigen TSP-180. Identity with α6-β4 in the integrin superfamily. J Biol Chem. 1989;264:15515-21. (IP, WB) | 3. | Sonnenberg A, Linders CJ. The α6β1 (VLA-6) and α6β4 protein complexes: tissue distribution and biochemical properties. J Cell Sci. 1990;96:207-17. (IP, WB, IHC-FS) | 4. | Gimond C, Baudoin C, van der Neut R, Kramer D, Calafat J, Sonnenberg A. Cre-loxP-mediated inactivation of the α6A integrin splice variant in vivo: evidence for a specific functional role of α6A in lymphocyte migration but not in heart development. J Cell Biol. 1998;143:253-66. (IP) | 5. | Mokkapati S, Fleger-Weckmann A, Bechtel M, Koch M, Breitkreutz D, Mayer U, et al. Basement membrane deposition of nidogen 1 but not nidogen 2 requires the nidogen binding module of the laminin γ1 chain. J Biol Chem. 2011;286:1911-8. (WB, IHC-FS) | 6. | Bagutti C, Wobus AM, Fässler R, Watt FM. Differentiation of embryonal stem cells into keratinocytes: comparison of wild-type and β1 integrin-deficient cells. Dev Biol. 1996;179:184-96. (FC, ICC) | 7. | Witkowski CM, Bowden GT, Nagle RB, Cress AE. Altered surface expression and increased turnover of the α6β4 integrin in an undifferentiated carcinoma. Carcinogenesis. 2000;21:325-30. (IP, FC, ICC) |
|